Phylogenetic comparison of influenza virus isolates from three medical centers in Tehran with the vaccine strains during 2008-2009

Iranian Journal of Medical Sciences

Volumn 36, Issue 3, 2011, Pages 172-177

  Mousavi, Seyedeh Fahime ^a,b   Kheiri, Masoumeh Tavassoti ^b   Hosseini, Seyed Masoud ^a   Taghizadeh, Mojgan ^c   Fotouhi, Fatemeh ^b   Heydarchi, Behnaz ^b   Bashar, Rouzbeh ^b   Gomari, Hosna ^b  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Hemagglutinin; Influenza a virus; Influenza vaccine; Sequence analysis

Indexed keywords

AMINO ACID; INFLUENZA VACCINE; VIRUS RNA;

AMINO ACID ANALYSIS; ARTICLE; CONTROLLED STUDY; FLU LIKE SYNDROME; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEMAGGLUTININ GENE; HOSPITAL; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; IRAN; MAJOR CLINICAL STUDY; NASOPHARYNX; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; THROAT CULTURE; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TYPING; WINTER; WORLD HEALTH ORGANIZATION;

EID: 80955133036     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Weis W, Brown JH, Cusack S, et al. Structure of the Influenza virus hemagglutinin complex with its receptor, sialic acid. Nature 1988; 333: 426-31.
2. Duwe S, Schweiger B, A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Methods 2008; 153: 134-11.
3. Shahidi M, Tavassoti Kheiri M, Amini-Bavil-Olyaee S, et al. Molecular and phylogenetic analysis of human influenza virus among Iranian patients in Shiraz, Iran. J Med Virol 2007; 79: 803-10.
4. Li OT, Barr I, Leung CY, et al. Reliable universal RT-PCR assays for studying influenza polymerase subunit gene sequences from all 16 hemagglutinin subtypes. J Virol Methods 2007; 142: 218-22.
5. Fitch WM, Bush RM, Bender CA, et al. Long term trends in the evolution of H (3) HA1 human influenza type A. Proc Natl Acad Sci 1977; 94: 7712-8.
6. Buonagurio DA, Nakada S, Parvin JD, et al. Evolution of human influenza A virus over 50 years: Rapid uniform rate change in NS gene. Science 1986; 232: 980-2.
7. Pontoriero VA, Baumeister GE, Campos AM, et al. Antigenic and genomic relation between human influenza A (H3N2) viruses circulating in Argentina during 1998 and the H3N2 vaccine component. Rev Panam Salud Publica 2001; 9: 246-53.
8. Both GW, Sleigh MJ, Cox NJ, Kendal AP. Influenza virus H3 Hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acidcharges at key antigenic sites. J Virol 1983; 48: 52-60.
9. Cox R J, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. comparison of the immune response to inactivated and live attenuated influenza vaccines. Scand J Immunol 2004; 59: 1-15.
10. Chutinimitkul S, Chieochansin T, Payungporn S, et al. Molecular characterization and phylogenetic analysis of H1N1 and H3N2 human influenza A viruses among infants and children in Thailand. Virus Res 2008; 132: 122-31.
11. Couch BR. Seasonal inactivated influenza virus vaccines. Vaccine 2008; 26: D5-9.
12. Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876-82.
13. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16: 111-20.
14. Saitou N, Nei M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-25.
15. Dopazo J. Estimating errors and confidence intervals for branch lengths in phylogenetic trees by a bootstrap approach. J Mol Evol 1994; 38: 300-4.
16. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-9.
17. Heydarchi B, Hosseini SM, Sheykhi N, et al. A molecular survey of Avian Influenza among captive birds in the city of Tehran between November 2008 and February 2009. Iranian J Microbiol 2009; 1: 32-5.
18. Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001; 356: 1861-70.
19. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2008-2009 northern hemisphere influenza season.
20. Mokhtari-Azad T, Mohammadi H, Moosavi IA, et al. Influenza surveillance in the Islamic republic of Iran from 1991 to 2001. East Mediterr Health J 2004; 10: 315-21.
21. Centers for Disease Control and Prevention: A weekly influenza surveillance report prepared by influenza division. (Cited: 12 October 2009) Available in: http://198.246.98.21/flu/weekly/weeklyarchives2008-2009/weekly42.htm.
22. Wilson I, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990; 8: 737-71.
23. Moattari A, Ashrafi H, Kadivar MR, et al. Antigenic variations of human influenza virus in Shiraz, Iran. Indian J Med Microbiol 2010; 28: 114-9.
24. Soltani Z, Hossein M, Shahidi M, et al. Molecular Analysis of Human Influenza Virus in Tehran, Iran. Intervirology 2009; 52: 63-7.
25. Daum LT, Canas LC, Smith CB, et al. Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas. Emerg Infect Dis 2002; 8: 408-12.